NCT04510961

Brief Summary

Objective: Chronic Hand eczema (CHE) is a common inflammatory skin disease has a major medical psychological and socio-economic implications that affect quality of life (QoL)and work ability. This study, the first randomized controlled trial that will be conducted to evaluate the effect of paraffin bath therapy (PBT) in the treatment of CHE.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 12, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 25, 2020

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

August 11, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 12, 2020

Completed
Last Updated

August 12, 2020

Status Verified

August 1, 2020

Enrollment Period

10 months

First QC Date

August 11, 2020

Last Update Submit

August 11, 2020

Conditions

Keywords

Paraffin bath therapy, Hand Eczema, SCORAD, DLQI, Itching

Outcome Measures

Primary Outcomes (1)

  • SCORAD ("SCORing Atopic Dermatitis

    is the most widely clinical tool for assessing the severity (i.e. extent, intensity) of atopic dermatitis as objectively as possible.20 It consists of six objective items (erythema, oedema/papules, effect of scratching, oozing/crust formation, lichenification, and dryness), and two subjective symptoms (itch and sleeplessness), the maximum score is 103 points

    Change from Baseline at SCORAD score at 6th week and at 12th weeks of treatment

Secondary Outcomes (1)

  • Dermatology life quality index (DLQI)

    Change from Baseline at 6th week and at 12th weeks of treatment

Study Arms (2)

Paraffin baths therapy (PBT) :group A

ACTIVE COMPARATOR

Patients in treatment group will receive paraffin wax baths for five days per week for 12 weeks.

Other: Paraffin baths therapy

Control group (B)

NO INTERVENTION

receive routine skin care program ; lifestyle change, emollients and moisturizers

Interventions

Patients in treatment group will receive paraffin wax baths for five days per week for 12 weeks. Prepare the paraffin device and blocks of paraffin wax. Put the paraffin wax blocks inside the tank and set the thermostat 35 to 40◦C. Melting paraffin was taken from 90 to 120 minutes. Adjust the suitable temperature for each patient before immersion of patient's hand. Submerge patient's hand completely for three to four seconds then withdraw it

Paraffin baths therapy (PBT) :group A

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age from 20-40 years
  • Time elapsed from the beginning of the disease ; more than three months according to the Guideline of the German Dermatological Society

You may not qualify if:

  • active eczematous lesions on other parts of the body;
  • malignant or premalignant skin tumors

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zizi Mohammed Ibrahim Ali

Riyadh, 2136, Saudi Arabia

Location

MeSH Terms

Conditions

EczemaPruritus

Condition Hierarchy (Ancestors)

DermatitisSkin DiseasesSkin and Connective Tissue DiseasesSkin Diseases, EczematousSkin ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Measurements will be at three occasions: at randomization (T1), at 6th week (T2) and at 12th week (T3) of treatment. Evaluative procedures will be by a blind assessor
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Sixty patients with moderate to severe Chronic Hand eczema (CHE) will participate in the study. They will be classified randomly into two groups of equal number; paraffin group and the control group. Interventions: Paraffin group will receive Paraffin Therapy for 5 days per week for 12 weeks in addition to routine skin care program while the control group will received routine skin care program
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
ASSOCIATE PROF

Study Record Dates

First Submitted

August 11, 2020

First Posted

August 12, 2020

Study Start

January 10, 2019

Primary Completion

November 12, 2019

Study Completion

January 25, 2020

Last Updated

August 12, 2020

Record last verified: 2020-08

Locations